TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC April 30, 2010
TCL Archive DCE Board Approves concept For New Studies On Black, White Differences In Cancer Rates July 13, 1984
TCL Archive 14th Cancer Congress Big Success; CICA Satellite Established; US, USSR Renew Cancer Agreement September 12, 1986
